Search results
Cramer: This chip stock is not on anyone's radar but is 'about to break out here'
CNBC· 4 days agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...
Jim Cramer Talks About 10 Consumer Stocks As Americans Push Back on High Prices
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will take a detailed look at Jim Cramer Talks About 10 Consumer Stocks As...
Jim Cramer says patience in Wynn Resorts will be rewarded after surprise post-earnings drop
CNBC· 6 days agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...
We're exiting a troubled drugmaker and putting the cash into 2 health-care stocks with brighter...
CNBC· 6 days agoIn addition, are buying 95 shares of Abbott Laboratories at roughly $104.53 and 125 shares of GE...
OpenAI gives a shoutout to Nvidia — plus, a new industrial stock joins our watchlist
CNBC· 1 day agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading ...
Starbucks should take a page from McDonald's to get customers back in its stores
CNBC· 4 days agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable...
Jim Cramer's top 10 things to watch in the stock market Friday
CNBC· 4 days agoMy top 10 things to watch Friday, May 10 Wall Street is poised for another higher open Friday. If...
Jim Cramer's top 10 things to watch in the stock market Wednesday
CNBC· 6 days agoMy top 10 things to watch Wednesday, May 8 Wall Street's winning streak may come to an end...
Tech sits out Thursday's rally as the S&P 500 inches closer to its March record
CNBC· 5 days agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable...
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
CNBC· 4 days agoIn a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed...